4//SEC Filing
VV Manager II, LLC 4
Accession 0000899243-20-026193
CIK 0001818794other
Filed
Sep 22, 8:00 PM ET
Accepted
Sep 23, 7:11 PM ET
Size
20.3 KB
Accession
0000899243-20-026193
Insider Transaction Report
Form 4
VV Manager II, LLC
10% Owner
Transactions
- Conversion
Common Stock
2020-09-21+2,087,130→ 2,087,130 total(indirect: See footnotes) - Purchase
Common Stock
2020-09-21$19.00/sh+22,005$418,095→ 79,921 total(indirect: See footnote) - Conversion
Series B Preferred Stock
2020-09-21−6,922,803→ 0 total(indirect: See footnotes)→ Common Stock (2,087,130 underlying) - Purchase
Common Stock
2020-09-21$19.00/sh+792,995$15,066,905→ 2,880,125 total(indirect: See footnotes) - Conversion
Common Stock
2020-09-21+57,916→ 57,916 total(indirect: See footnote) - Conversion
Series B Preferred Stock
2020-09-21−192,102→ 0 total(indirect: See footnote)→ Common Stock (57,916 underlying)
Vida Ventures II, LLC
10% Owner
Transactions
- Conversion
Common Stock
2020-09-21+57,916→ 57,916 total(indirect: See footnote) - Conversion
Common Stock
2020-09-21+2,087,130→ 2,087,130 total(indirect: See footnotes) - Purchase
Common Stock
2020-09-21$19.00/sh+22,005$418,095→ 79,921 total(indirect: See footnote) - Conversion
Series B Preferred Stock
2020-09-21−6,922,803→ 0 total(indirect: See footnotes)→ Common Stock (2,087,130 underlying) - Conversion
Series B Preferred Stock
2020-09-21−192,102→ 0 total(indirect: See footnote)→ Common Stock (57,916 underlying) - Purchase
Common Stock
2020-09-21$19.00/sh+792,995$15,066,905→ 2,880,125 total(indirect: See footnotes)
VIDA VENTURES II-A, LLC
10% Owner
Transactions
- Conversion
Common Stock
2020-09-21+2,087,130→ 2,087,130 total(indirect: See footnotes) - Purchase
Common Stock
2020-09-21$19.00/sh+792,995$15,066,905→ 2,880,125 total(indirect: See footnotes) - Conversion
Common Stock
2020-09-21+57,916→ 57,916 total(indirect: See footnote) - Conversion
Series B Preferred Stock
2020-09-21−6,922,803→ 0 total(indirect: See footnotes)→ Common Stock (2,087,130 underlying) - Conversion
Series B Preferred Stock
2020-09-21−192,102→ 0 total(indirect: See footnote)→ Common Stock (57,916 underlying) - Purchase
Common Stock
2020-09-21$19.00/sh+22,005$418,095→ 79,921 total(indirect: See footnote)
Footnotes (4)
- [F1]On September 21, 2020, the Series B Preferred Stock automatically converted into Common Stock on a 3.3169-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
- [F2]The shares are held directly by Vida Ventures II, LLC ("Vida II"). VV Manager II, LLC ("VV Manager II") is the manager of Vida II. Arie Belldegrun, Fred Cohen, and Leonard Potter are the members of the management committee of VV Manager II (the "Management Committee") and Stefan Vitorovic, Arjun Goyal, Helen Kim, Rajul Jain, and Joshua Kazam are the members of the investment committee of VV Manager II (the "Investment Committee").
- [F3](Continued from Footnote 2) Each of the Management Committee, the Investment Committee and the respective members thereof may be deemed to share voting and dispositive power over the shares held by Vida II. VV Manager II, the Management Committee, the Investment Committee and each member of each of the Management Committee and Investment Committee disclaims beneficial ownership over the securities held of record by Vida II and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein.
- [F4]The shares are held directly by Vida Ventures II-A, LLC ("Vida II-A"). VV Manager II is the manager of Vida II-A. Each of the Management Committee ,the Investment Committee and the respective members thereof may be deemed to share voting and dispositive power over the shares held by Vida II-A. VV Manager II, the Management Committee, the Investment Committee and each member of each of the Management Committee and Investment Committee disclaims beneficial ownership over the securities held of record by Vida II-A and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein.
Documents
Issuer
Dyne Therapeutics, Inc.
CIK 0001818794
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001824569
Filing Metadata
- Form type
- 4
- Filed
- Sep 22, 8:00 PM ET
- Accepted
- Sep 23, 7:11 PM ET
- Size
- 20.3 KB